TickerFactsScreenerDevelopers

Anika Therapeutics, Inc. (ANIK) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $43.19M2009: $24.43M2010: $28.20M2011: $35.78M2012: $44.07M2013: $63.33M2014: $100.16M2015: $110.71M2016: $104.26M2017: $133.26M2018: $89.04M2019: $157.46M2020: $95.82M2021: $94.39M2022: $86.33M2023: $68.74M2024: $55.63M2025: $57.48M$57.48M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$57.48M+3.3%
2024$55.63M-19.1%
2023$68.74M-20.4%
2022$86.33M-8.5%
2021$94.39M-1.5%
2020$95.82M-39.1%
2019$157.46M+76.8%
2018$89.04M-33.2%
2017$133.26M+27.8%
2016$104.26M-5.8%
2015$110.71M+10.5%
2014$100.16M+58.1%
2013$63.33M+43.7%
2012$44.07M+23.2%
2011$35.78M+26.9%
2010$28.20M+15.5%
2009$24.43M-43.4%
2008$43.19M—